Related references
Note: Only part of the references are listed.Fabry disease: a review of current management strategies
A. Mehta et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Gastrointestinal symptoms in 342 patients with Fabry disease: Prevalence and response to enzyme replacement therapy
Bjoern Hoffmann et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Enzyme replacement therapy with agalsidase alfa in children with Fabry disease
U. Ramaswami et al.
ACTA PAEDIATRICA (2007)
Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey)
B Hoffmann et al.
JOURNAL OF MEDICAL GENETICS (2005)
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy
C Whybra et al.
CLINICAL GENETICS (2004)
Prevalence of lysosomal storage diseases in Portugal
R Pinto et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain
S Keller et al.
CLINICAL JOURNAL OF PAIN (2004)
Share Paper
